Julio Celis, Chairman of the Science Policy Committee of the European Academy of Cancer Sciences; Danish Cancer Society Research Center, Copenhagen. Associated Scientific Director of the Danish Cancer Society Research Center. He has been Chairman of the European Molecular Biology Laboratory (EMBL) Council (1997-1999), Vice President of the Human Proteome Organization (HUPO; 2002), Chair of the Initiative for Science in Europe (ISE; 2005-2007), President of the European Molecular Biology Conference (EMBC/EMBO; 2000-2003), Secretary General of the Federation of European Biochemical Societies (FEBS; 1999-2007), President of the European Life Sciences Forum (ELSF; 2001-2007), President of the European Association for Cancer Research (2012-2014), Chairman of the Policy Committee of the European CanCer Organisation (ECCO; 2008-2014), and Vice-President of the Alliance for Biomedical Research in Europe (2011-2014). He is currently Advisor to the Scientific Panel for Health in Horizon 2020 (2015-), member of the European Commission Research, Innovation and Science Experts (RISE) High-Level Advisory Board (2015-), Chairman of the Science Policy Committee of the EACS, and Editor-in-Chief of Molecular Oncology (2007-). Prof Celis has organized several international laboratory courses, Summer Schools, and Congresses and is generally recognized as one of the founding fathers of proteomics. He is member of the Royal Danish Academy of Sciences and Letters, the European Molecular Biology Organization (EMBO), the Academia Europaea, the European Academy of Cancer Sciences (EACS), and the Chilean Academy of Sciences.
"Las opiniones expresadas por los ponentes no reflejan, necesariamente, las de la Fundación Ramón Areces ni de las instituciones en las que trabajan"